Biomarkers of anti-angiogenic therapy in metastatic colorectal cancer (mCRC): original data and review of the literature. [electronic resource]
Producer: 20120322Description: 1398-406 p. digitalISSN:- 1439-7803
- AC133 Antigen
- Aged
- Angiogenesis Inhibitors -- administration & dosage
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Antigens, CD -- blood
- Antigens, CD34 -- blood
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bevacizumab
- Biomarkers -- blood
- Cell Count
- Colorectal Neoplasms -- blood supply
- Disease Progression
- Endothelial Cells -- drug effects
- Endothelium, Vascular -- drug effects
- Female
- Flow Cytometry
- Glycoproteins -- blood
- Humans
- Immunohistochemistry
- Male
- Middle Aged
- Peptides -- blood
- Pilot Projects
- Stem Cells -- drug effects
- Treatment Outcome
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Vascular Endothelial Growth Factor Receptor-2 -- blood
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.